Danaher Corporation (DAP.DE)

231,75 +3,55 (+1,56%) Börsenschluss: 05:35PM CEST

Danaher Corporation

2200 Pennsylvania Avenue, NW
Suite 800W
Washington, DC 20037-1701
United States
202 828 0850
https://www.danaher.com

Sektor(en): Healthcare
Branche: Diagnostics & Research
Vollzeitmitarbeiter: 79.000

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Steven M. Rales	Co-Founder & Chairman	N/A	N/A	1951
Mr. Rainer M. Blair	Pres, CEO & Director	5,93M	5,83M	1964
Mr. Mitchell P. Rales	Co-Founder & Director	N/A	N/A	1957
Mr. Matthew R. McGrew	CFO & Exec. VP	2,85M	4,12M	1972
Dr. Jose-Carlos Gutierrez-Ramos Ph.D.	Sr. VP & Chief Science Officer	2,24M	N/A	1963
Mr. Joakim Weidemanis	Exec. VP	3,13M	6,28M	1969
Ms. Jennifer L. Honeycutt	Exec. VP	2,56M	1,64M	1970
Mr. Christopher M. Bouda	VP & Chief Accounting Officer	N/A	N/A	N/A
Mr. John Bedford	VP of Investor Relations	N/A	N/A	N/A
Mr. Brian W. Ellis	Sr. VP, Gen. Counsel & Chief Compliance Officer	N/A	N/A	1967

Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

Corporate Governance

Danaher Corporations ISS Governance QualityScore, Stand 30. März 2023, lautet 3. Die grundlegenden Scores sind Audit: 6, Vorstand: 8, Shareholderrechte: 3, Kompensation: 1.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.